Word: chiron
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...still manages to suggest the violence in some interesting ways--most notably the scene in which Tamora, Queen of the Goths, and her sons Demitrius and Chiron, seek audience with Titus: it's transplanted into Titus' bath, accentuating the play's obsession with human flesh. Indeed, as if to further this alternative method of presenting this obsession, nearly all of the principal characters at some point or other are at least partially undressed. However, music, sound and lighting, much more than the actual set, are used to evoke an eerie, faintly unearthly atmosphere, and do so effectively. This is more...
...trying to win sympathy. Nor do they strive for the kind of perfect diction and modulation one normally expects from performance of Shakespeare. Instead, they play up the wild distortions, creating a melange of half-bestial, half-diabolical passions. As the two unredeemable villains of the play, Demitrius and Chiron, Kelly Keough and Chuck O'Toole '97 are costumed and made up to resemble a cross between macabre spirits and S&M partygoers--an image reinforced, perhaps overdone, by slinking movements and exaggerated gestures. As their victim, Lavinia, Zimmett grows more like them in her thirst for revenge--which...
...concerns that seem to show the most promise. "Many, many companies have scrambled to get into the race," notes Ed Hurwitz, an analyst for Robertson, Stephens & Co. The list of recent mergers, as Hurwitz ticks them off, reads like a Who's Who of biotechnology: "Sandoz buys Genetics Institute. Chiron buys Viagene. Bristol Myers makes a big investment in Somatix. Merck makes a big investment in Vical. Rhone-Poulenc invests in Applied Immune Sciences and several other gene-therapy companies...
...results from the clinical trial in which Arens has been participating. The study showed that patients receiving a recombinant form of beta interferon did better than those getting the placebo. The difference was quite dramatic for those patients who received high dosages of the drug, which is manufactured by Chiron Corp. and Berlex Laboratories. Compared with the control group, high- dose patients suffered 50% fewer serious attacks of the disease, and those attacks were of shorter duration. Moreover, brain scans revealed that this group of patients incurred fewer central nervous system lesions, suggesting that the therapy may be more than...